Neoadjuvant/Adjuvant GVAX Pancreas Vaccine (With CY) With or Without Nivolumab Trial for Surgically Resectable Pancreatic Cancer

Clinical Trial ID NCT02451982

PubWeight™ 5.43‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02451982

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Current progress in immunotherapy for pancreatic cancer. Cancer Lett 2015 0.83
2 Improving the clinical impact of biomaterials in cancer immunotherapy. Oncotarget 2016 0.83
3 Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors. Cancer Biol Med 2015 0.80
4 Immune checkpoint therapy for pancreatic cancer. World J Gastroenterol 2016 0.79
5 Metabolic regulation of immune responses: therapeutic opportunities. J Clin Invest 2016 0.75
6 Immune checkpoint and inflammation as therapeutic targets in pancreatic carcinoma. World J Gastroenterol 2016 0.75
7 Pancreatic cancer: Update on immunotherapies and algenpantucel-L. Hum Vaccin Immunother 2016 0.75
Next 100